Your search for supplemental oxygen returned 32 results

Lower average oxygen delivery rates seen in association with Asian, Black, Hispanic versus White race, ethnicity

Investigators report findings from a secondary analysis of the DARE-19 trial, which compared dapagliflozin with placebo in patients hospitalized with COVID-19.

Shortly after an EUA was issued, Genentech announced that tocilizumab (marketed under the brand name Actemra) was in shortage.

The EUA was issued based on 4 randomized controlled clinical trials that evaluated the efficacy and safety of Actemra in more than 5500 hospitalized patients with COVID-19.

Findings showed that the trial did not meet statistical significance on the primary endpoint.

Authors call for larger clinical trials to further evaluate the efficacy and safety of colchicine as an adjunctive therapy for COVID-19

Investigators evaluated the relationship between atopic dermatitis and frequency of severity markers in patients hospitalized with COVID-19.

Intubation or death, disease worsening similar for tocilizumab, placebo in hospitalized patients.

Dexamethasone appears promising for patients with severe illness.

No significant difference seen in five-, 10-day course for severe COVID-19 without mechanical ventilation.